Constipation, a common clinical condition, often presents a diagnostic and management challenge to clinicians. This condition, characterized by infrequent bowel movements, hard stools, straining during defecation, and a sensation of incomplete evacuation, is often a symptom of underlying gastrointestinal disorders. Therefore, a comprehensive approach is essential for effective diagnosis and management.
Diagnosis begins with a thorough patient history and physical examination. The Rome IV criteria, which includes infrequent bowel movements, hard stools, and straining, can be used as a diagnostic tool. In some cases, additional diagnostic tests such as blood tests, colonoscopy, or radiographic studies may be necessary to exclude other conditions such as colorectal cancer, inflammatory bowel disease, or thyroid dysfunction.
Management of constipation involves both non-pharmacological and pharmacological approaches. Lifestyle modifications including increased dietary fiber intake, regular physical activity, and adequate hydration are the first line of treatment. If these measures are ineffective, pharmacological interventions such as laxatives, stool softeners, and prokinetic agents can be considered. In refractory cases, newer therapies such as biofeedback and sacral nerve stimulation may be explored.
Despite the availability of various treatment options, many patients continue to suffer from constipation due to inadequate response to therapy, side effects, or lack of long-term efficacy. Therefore, there is a need for more effective and safer therapeutic options. Emerging therapies such as peripherally acting mu-opioid receptor antagonists and guanylate cyclase-C agonists show promise and may change the landscape of constipation management in the future.
Constipation is a complex clinical condition requiring a comprehensive approach for effective diagnosis and management. Clinicians should remain abreast of the latest diagnostic criteria and management strategies, including emerging therapies, to provide optimal care to their patients.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation